1.2094
Finanzdaten der Barinthus Biotherapeutics Plc Adr-Aktie (BRNS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
96.05%
0.013
|
0.329 | - | 14.97 | 0.577 |
|
|
11.51%
23.34
|
20.93 | 23.57 | 24.56 | 18.86 |
| Benefits Costs and Expenses |
5.77%
21.16
|
20.01 | 20.59 | 23.10 | 17.53 |
| Costs And Expenses |
11.51%
23.34
|
20.93 | 20.59 | 23.10 | 18.86 |
| Other Operating Income/Expenses |
96.05%
0.013
|
0.329 | 0.184 | 0.21 | 0.577 |
| Operating Income/Loss |
13.22%
-23.32
|
-20.60 | -23.39 | -9.38 | -18.29 |
| Nonoperating Income/Loss |
136.20%
2.173
|
0.92 | 2.802 | 1.248 | 1.336 |
| Income/Loss From Continuing Operations Before Tax |
7.47%
-21.15
|
-19.68 | -20.59 | -8.132 | -16.95 |
| Income Tax Expense/Benefit, Deferred |
13.64%
-0.025
|
-0.022 | 0.003 | -0.003 | -0.007 |
| Income Tax Expense/Benefit |
13.64%
-0.025
|
-0.022 | 0.003 | -0.003 | -0.007 |
| Income/Loss From Continuing Operations After Tax |
7.47%
-21.13
|
-19.66 | -20.59 | -8.129 | -16.94 |
|
|
7.47%
-21.13
|
-19.66 | -20.59 | -8.129 | -16.94 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
80.00%
-0.002
|
-0.01 | -0.051 | -0.015 | -0.012 |
| Basic Average Shares |
0.19%
40.34
|
40.27 | 0.269 | 39.42 | 39.04 |
| Diluted Average Shares |
0.19%
40.34
|
40.27 | 0.269 | 39.42 | 39.04 |
| Basic Earnings Per Share |
6.12%
-0.52
|
-0.49 | -0.51 | -0.21 | -0.43 |
| Diluted Earnings Per Share |
6.12%
-0.52
|
-0.49 | -0.51 | -0.21 | -0.43 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):